Abstract
Aims
Hb Toranomon [β112 (G14) Cys → Try] was the variant hemoglobin first reported by Harano et al. (Hemoglobin 20:361–369, 1996). Since 2004 there have been successive reports of Hb Toranomon based on abnormal HbA1c levels measured by high-performance liquid chromatography (HPLC). HbA1c levels are known to vary depending on the HPLC model used. We compared the HbA1c measured by new and old HPLC models in patients with Hb Toranomon.
Method
Eight patients with Hb Toranomon (5 men, 3 women; 4 with diabetes and 4 without diabetes; 7 heterozygotes, 1 homozygote) were studied. HbA1c levels measured using the old HPLC models (Arkray HA-8150 and Tosoh GHb III) and the new HPLC models (Arkray HA-8160 or later, Tosoh GHbV or later) were compared with the results of immunoassay, enzymatic assay, affinity assay of HbA1c, and glycated albumin (GA).
Results
HbA1c levels measured by the old and new Arkray models were 10 and 30% lower, respectively, and those measured by the new Tosoh models were 30% higher than the results of immunoassay. The same trends were found in comparisons with the HbA1c results of enzymatic and affinity assays or GA.
Conclusion
Glycated variant hemoglobins, such as Hb Toranomon, may have previously been measured as HbA1c and are difficult to identify because of the low divergence from other glycemic control indicators in the old HPLC models. The recent detection of successive Hb Toranomon patients is likely due to the abnormally low or high HbA1c levels by the upgraded measuring models.
Similar content being viewed by others
References
Wajcman H. Human hemoglobin variants, the electric versions. http://globin.cse.psu.edu. Accessed 15 June 2011.
Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2001;47:153–63.
Schnedl WJ, Krause R, Halwachs-Baumann G, Trinker M, Lipp RW, Krejs GJ. Evaluation of HbA1c determination methods in patients with hemoglobinopathies. Diabetes Care. 2000;23:339–44.
Thomas LB, Agosti SJ, Man MA, Mastorides SM. Screening for hemoglobinopathies during routine hemoglobin A1c testing using the Tosoh G7 Glycohemoglobin Analyzer. Ann Clin Lab Sci. 2007;37:251–5.
Harano T, Harano K, Kawasaki R, Kawakami K. Hb Toranomon [beta112 (G14) Cys → Trp]: a new unstable electrophoretically silent hemoglobin. Hemoglobin. 1996;20:361–9.
Ohguni S, Ohta M, Kondo A, Harano K. A case with variant hemoglobin (Hb Toranomon) found because of high value of HbA1c. J Japan Diab Soc. 2005;48:443. (in Japanese).
Shioji H, Ohguni S, Doi Y. A case with Hb Toranomon whose HbA1c levels measured by two HPLC models showed a discrepancy. J Japan Diab Soc. 2009;52:983. (in Japanese).
Haga Y, Kikuchi K, Ohmiya Y, Hosoya E, Matsumori Y, Igarashi M, Miyazaki A. A case with variant hemoglobin found in HbA1c measurement. J Jpn Soc Lab Hematol. 2007;8(Suppl):S96. (in Japanese).
Miyazaki A, Takubo T. Identification of abnormal hemoglobin by electrospray ionization mass spectrometry: three cases with Hb Toranomon (β112 Cys → Trp). Abstract of the 32nd annual meeting of Jpn Soc Biomed Mass Spectrom. 2007;32:65 (in Japanese).
Morita T, Nagashima M, Hirano T, Harano K, Sato M. A case of Hb Toranomon with apparently high value of HbA1c experienced hypoglycemia after administration of oral hypoglycemic drug. The 48th local meeting abstract of Kanto-Kohshinetsu in Japan Diab Soceity; 2011. p. 69 (in Japanese).
Hamaguchi K, Yamashita T, Kusuda Y, Oribe A, Yoshimatsu H, Abe N. A case with variant hemoglobin was difficult to find because of mild abnormalities of HbA1c value. J Japan Diab Soc. 2004;47:678. (in Japanese).
Ijima H, Miyazaki M, Kawaguchi H, Hashiguchi K, Nishimura H, Eguchi A, Ikeda A, Jinnouchi H, Kajihara K, Jinnouchi T. Two diabetic cases with Hb Toranomon whose HbA1c showed apparently low. J Japan Diab Soc. 2009;50:499–503. (in Japanese).
Chapelle JP, Teixeira J, Maisin D, Assink H, Barla G, Stroobants AK, Delzenne B, van den Eshof W. Multicentre evaluation of the Tosoh HbA1c G8 analyser. Clin Chem Lab Med. 2010;48:365–71.
Schnedl WJ, Lahousen T, Wallner SJ, Krause R, Lipp RW. Silent hemoglobin variants and determination of HbA1c with the high-resolution program of the HPLC HA-8160 hemoglobin analyzer. Clin Biochem. 2005;38:88–91.
The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest. 2010;1:212–28.
Kouzuma T, Uemastu Y, Usami T, Imamura S. Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method. Clin Chim Acta. 2004;346:135–43.
Miura N, Suganuma T, Yamamura Y. HbA1c levels in diabetic patients with variant hemoglobin. Jap J Med Technol. 2008;57:515. (in Japanese).
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62–9.
Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol. 2004;112:126–8.
Hasegawa A, Harano K, Harano A, Ito Y, Horimoto K, Mikami H. A case with variant hemoglobin (Hb Toranomon) found in medical checkup. J Japan Diab Soc. 2005;48:139. (in Japanese).
Tomita M, Kabeya Y, Okada K, Shirai M, Asai S, Katsuki T, Oikawa Y, Shimada A, Harano K, Atsumi Y. Normal glucose tolerance with high HbA1c levels observed in two cases of Hb variants. Diabetol Int. 2010;1:104–7.
Nishihara E, Koga M, Kadowaki S, Murakami M, Harano K, Ito M, Kubota S, Amino N, Miyauchi A. Method-dependent HbA1c values in a family with hemoglobin Himeji. Clin Chim Acta. 2011;412:1689–92.
Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J. 2010;57:751–62.
Conflict of interest
None of the authors have conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ijima, H., Jinnouchi, H., Hamaguchi, K. et al. Cases with Hb Toranomon show abnormal HbA1c levels measured by upgraded high-performance liquid chromatography models. Diabetol Int 2, 202–207 (2011). https://doi.org/10.1007/s13340-011-0045-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13340-011-0045-8